John Libbey Eurotext

Journal de Pharmacie Clinique

MENU

Process control for purchasing health products in a pharmaceutical distribution company Volume 41, issue 4, Décembre 2022

Figures


  • Figure 1.

  • Figure 2.

Tables

Authors
1 Pharm D, PhD, Enseignant chercheur, Laboratoire de pharmacie galénique, sciences de gestion, Faculté de médecine, de pharmacie et d’odontologie, Université Cheikh Anta Diop, Dakar, Sénégal
2 Médecin, Enseignant chercheur, Université Alioune Diop, Bambey, Sénégal
Correspondance : D. Faye

Pharmaceutical distribution companies are exposed to risks that can have a negative impact on the control of the health product purchasing process. This study aims to identify and analyze these risks in order to propose the means to contain them and to seek the best possible coverage. This is a qualitative method carried out in a focus group with the staff of a pharmaceutical distribution company in Ivory Coast as part of a thesis in pharmacy. À total of five risks have been identified in the purchasing process. These were in particular the poor estimation of needs, the poor choice of suppliers, and non-compliance with the general conditions of purchase, fraud and supplier favoritism.